In experiments on isolated preparations of segments of the aorta and portal vein, we demonstrated that endothelium-dependent reactions of vascular smooth muscles (SMs) are suppressed in rats subjected to destruction of the nigro-striatal dopaminergic system in the left hemisphere (model of hemiparkinsonims). Under such conditions, the amplitude of relaxation of SMs of the wall of the thoracic aorta upon the action of the endothelium-dependent vasodilator acetylcholine iodide was four times smaller, while the latency demonstrated a 3.5-fold increase, as compared with the control. The amplitude of relaxation of vascular SMs after application of the endothelium-independent vasodilator sodium nitroprusside remained practically unchanged. In addition, preliminary stretching-induced increments of the amplitude of phasic contractions of the portal vein demonstrated a 2.5-fold decrease; this increment reached the maximum at smaller additional loadings, while the rigidity of the vascular wall increased. In animals that obtained a preparation of coenzyme Q10 (10 mg/kg) with food during one month, contractile reactions of vascular SMs partly recovered. The amplitude of endothelium-dependent relaxation of the aorta increased, the latency of this reaction shortened, stretching-induced increments of the amplitude of phasic contractions increased, and the rigidity of the vascular wall dropped. We conclude that the functional state of the endothelium is worsened, and the vascular reactivity is modified under conditions of chronic insufficiency of nigro-striatal dopamine. It seems probable that oxidative stress is one of the main reasons for such changes. Coenzyme Q10 significantly normalized abnormal vascular reactions (perhaps, due, to a considerable extent, to its antioxidant properties).
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
E. A. Alimova and V. L. Golubev, “Autonomous disorders in Parkinson’s disease,” Zh. Nevropatol. Psikhiat., 92, No. 5, 48–52 (1992).
V. L. Golubev, Ya. I. Levin, and A. M. Vein, Parkinson’s Disease and Syndrome [in Russian], Medpress, Moscow (2000).
S. A. Talanov, M. N. Tkachenko, O. V. Bazilyuk, et al., “Effect of enalapril on vasomotor reactions in rats with chronic dopamine insufficiency in the mesencephalo-striatal system,” Fiziol. Zh., 53, No. 3, 16–22 (2007).
V. M. Mann, J. M. Cooper, D. Krige, et al., “Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson’s disease,” Brain, 115, Part 2, 333–342 (1992).
A. H. Schapira, M. Gu, J. W. Taanman, et al., “Mitochondria in the etiology and pathogenesis of Parkinson’s disease,” Ann. Neurol., 44, No. 3, Suppl. 1, S89–S98 (1998).
P. Jenner and C. W. Olanow, “Oxidative stress and the pathogenesis of Parkinson’s disease,” Neurology, 47, No. 6, Suppl. 3, S161–S170 (1996).
P. Jenner, “Oxidative mechanisms in nigral cell death in Parkinson’s disease,” Mov. Disord., 13, Suppl. 1, 24–34 (1998).
S. A. Talanov, N. N. Oleshko, M. N. Tkachenko, and V. F. Sagach, “Pharmacoprotective influences on different links of the mechanism underlying 6-hydroxydopamine-induced degeneration of nigro-striatal dopaminergic neurons,” Neurophysiology, 38, No. 2, 128–133 (2006).
A. H. Tsang and K. K. Chung, “Oxidative and nitrosative stress in Parkinson’s disease,” Biochim. Biophys. Acta, 30 (2008).
M. E. Götz, G. Künig, P. Riederer, and M. B. Youdim, “Oxidative stress: free radical production in neural degeneration,” Pharm. Theor., 63, No. 1, 37-122 (1994).
N. K. Zenkov, V. Z. Lankin, and E. B. Men’shikova, Oxidative Stress. Biochemical and Pathophysiological Aspects [in Russian], Nauka/Interperiodika, Moscow (2001).
M. N. Tkachenko, V. F. Sagach, A. V. Kotsyuruba, et al., “Endothelium-dependent contractile reactions of vascular smooth muscles and the content of free oxygen radicals in aging rats,” Fiziol. Zh., 48, No. 4, 3–13 (2002).
T. P. Pobezhimova and V. K. Voinikov, “Biochemical and physiological aspects of the functioning of ubiquinone,” Biol. Membr., 16, No. 5, 485–491 (1999).
B. Frei, M. C. Kim, and B. N. Ames, “Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations,” Proc. Natl. Acad. Sci. USA, 87, No. 12, 4879–4883 (1990).
Author information
Authors and Affiliations
Corresponding author
Additional information
Neirofiziologiya/Neurophysiology, Vol. 41, No. 3, pp. 206–211, May–June, 2009.
Rights and permissions
About this article
Cite this article
Talanov, S.A., Tkachenko, M.N., Bazilyuk, O.V. et al. Chemo- and Mechano-Induced Reactions of Vascular Smooth Muscles in Rats with Chronic Insufficiency of Cerebral Dopamine: Effect of Co-Enzyme Q10 . Neurophysiology 41, 171–175 (2009). https://doi.org/10.1007/s11062-009-9096-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-009-9096-x

